Skåne, 14 January 2025 - Strict regulatory requirements and the need for automation in production are at the heart of the biggest challenges and opportunities in Skåne's life science sector, according to a new qualitative study by Syno, commissioned by Plantvision, a leading player in quality assurance, compliance and digitalization. Of Sweden's approximately 4,000 life science companies, 820 are based in Skåne, a region with great potential for growth and innovation.
The qualitative study, which interviewed 31 life science companies in Skåne, highlights crucial factors for strengthening competitiveness and driving innovation in the sector.
Insights that highlight the industry's biggest challenges and opportunities:
- Regulatory requirements slow down innovation
Strict and complex regulations are the biggest barrier to innovation according to 42% of respondents. In addition, slow market approval processes and high documentation requirements increase workloads, limiting companies' ability to act quickly. - Digitalization offers great opportunities but also creates obstacles
22% of respondents highlight the need for digitalization to streamline production processes. This includes prioritizing the automation of quality controls and documentation, while many point to financial resources and time for implementation as significant barriers. - Skills - a catalyst for growth
26% of companies identify the need for excellence in validation and qualification as crucial for growth, with 13% of respondents also emphasizing the importance of knowledge in GMP and regulatory compliance for successful expansion. An equal number, 13%, cite a need for expertise in process automation and digitalization.
The right support opens the door to innovation
The extensive regulations in life sciences can be difficult for smaller companies to navigate without affecting their core focus on research and development. With the right compliance support, these companies can reallocate resources and accelerate the pace of innovation without compromising regulatory compliance.
- Life science companies face the dual challenge of balancing strict requirements with the need for innovation and efficiency. Compliance and regulations need to be integrated early in the development process to avoid costly mistakes later. With our experience, we help companies to choose the right systems and processes that support production and regulations, strengthening their growth and competitiveness," says Cecilia Fällman, Business Area Manager for Compliance at Plantvision.
Running a life science company requires a balance between production, quality and regulatory requirements. By optimizing processes from development to production, companies can meet market needs while driving innovation and growth.
- By digitalize and automating manufacturing processes, life science companies can not only streamline their production, but also ensure high quality and faster delivery to the market. With the right system solutions and technical excellence, we can help companies optimize their processes, meet regulatory requirements and strengthen their competitiveness in a dynamic and demanding industry," develops Cecilia Jacobsson, Business Area Manager for Technology at Plantvision.
About the survey
On behalf of Plantvision,Syno International has conducted a qualitative survey among 31 life science companies in the Skåne region. The interviews were conducted during two weeks in November 2024.
For more information, please contact:
Björn Dahlgren, Northern Link PR for Plantvision
bjorn@nlpr.se
Cecilia Fällman, Business Area Manager for Compliance, Plantvision AB
cecilia.fallman@plantvision.se
Cecilia Jacobsson, Business Area Manager for Technology, Plantvision AB
cecilia.jacobsson@plantvision.se
